National Cancer Institute, www.cancer.gov
Cancer Centers Program
Downloads  |  FAQ  |  Site Map
Cancer Centers Grants and Funding News and Events About Us

Home > Cancer Centers List > Masonic Cancer Center
Masonic Cancer Center
University of Minnesota
University of Minnesota Cancer Center
Comprehensive Cancer Center
Director: Douglas Yee, M.D.
MMC 806
420 Delaware Street, S.E. 
Minneapolis MN 55455 
Toll Free (MN, WI, IA, ND, SD)
(888) CANCER M (226-2376)
Info Tel: (612) 624-2620
Administrative Office
Tel: (612) 624-8484
Fax: (612) 626-3069 
Visit Website
Clinical Trials at this Center

The mission of the University of Minnesota Cancer Center is to advance knowledge about cancer and enhance care. The Cancer Center is an NCI comprehensive matrix center with 8 research programs and 12 shared resource cores. The research programs, which encompass clinical, basic and population research, are: Breast Cancer, Cancer Progression and Metastasis, Immunology, Transplant Biology and Therapy, Carcinogenesis and Chemoprevention, Genetic Mechanisms of Cancer, Translational Research, and Prevention and Etiology. Over 200 Cancer Center members have been awarded more than $70 million annually in national peer reviewed research grants. The center is part of the University’s Academic Health Center which includes the Medical School, Dental School, Schools of Public Health, Nursing and Veterinary Medicine. Other research partners include Institute of Human Genetics, Stem Cell Institute, Center for Immunology, and the Tobacco Use Research Center, and Center for Magnetic Resonance Imaging. Clinical research and service partners include the University of Minnesota Medical Center, Fairview and University of Minnesota Physicians. The center benefits from broad community interactions including: participation in the Minnesota Cancer Alliance, extensive philanthropy and a community advisory board.


Research strengths include:

  • tobacco research and lung carcinogenesis,
  • murine models of oncogene discovery,
  • experimental and clinical hematopoietic stem cell transplantation,
  • risk factors in development of pediatric cancers and
  • experimental and clinical studies of bone pain in cancer.